Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia
![mainstay-300x300](https://ipfpartners.com/wp-content/uploads/2019/05/mainstay-300x300.jpg)
Mainstay Medical Holdings plc today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain.
Mainstay Medical Holdings plc today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain.